Global Vertebroplasty and Kyphoplasty Device Market Size By Type (Needles, Balloons), By Application (Hospital, Ambulatory Surgery Center), By Region, And Segment Forecasts, 2023 to 2032

Report Id: 23462 | Published Date: Mar 2026 | No. of Pages: | Base Year for Estimate: Mar 2026 | Format:


The Global Vertebroplasty and Kyphoplasty Device Market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2023-2031). The market's growth is primarily driven by the increasing prevalence of osteoporosis, rising geriatric population, and advancements in minimally invasive spinal procedures. Vertebroplasty and kyphoplasty devices play a crucial role in treating vertebral compression fractures (VCFs), offering pain relief and restoring vertebral height.

Technological advancements in imaging and navigation systems, along with the rising demand for minimally invasive procedures, are further fueling the adoption of these devices. Additionally, growing awareness regarding early diagnosis and treatment of spinal conditions is expected to drive market expansion.

Market Drivers

Increasing Prevalence of Osteoporosis and Spinal Fractures

The rising incidence of osteoporosis, especially among the aging population, is a key driver of the vertebroplasty and kyphoplasty device market. Osteoporotic fractures, particularly in the spine, lead to significant pain, disability, and reduced quality of life, thereby increasing the demand for these procedures.

Rising Adoption of Minimally Invasive Procedures

Minimally invasive surgical techniques such as vertebroplasty and kyphoplasty offer several benefits over conventional open surgeries, including reduced hospital stays, lower risk of infection, and quicker recovery times. The shift towards minimally invasive procedures is expected to drive market growth.

Technological Advancements in Spinal Treatment Devices

Continuous innovation in biomaterials, navigation systems, and imaging technologies has enhanced the precision and success rates of vertebroplasty and kyphoplasty procedures. Advanced balloon kyphoplasty systems and bone cement materials are improving procedural efficiency and outcomes.

Market Restraints

High Cost of Procedures and Devices

The high cost of vertebroplasty and kyphoplasty procedures, along with expensive imaging systems required for guidance, poses a challenge, particularly in cost-sensitive markets. Reimbursement policies and access to healthcare services also impact market penetration.

Complications and Post-Surgical Risks

Despite their benefits, vertebroplasty and kyphoplasty procedures are associated with certain risks, such as cement leakage, adjacent vertebral fractures, and neurological complications. Concerns over potential post-surgical risks may limit adoption among some patients and healthcare providers.

Market Opportunities

Growing Demand in Emerging Markets

Emerging economies in Asia-Pacific and Latin America present significant growth opportunities due to the increasing aging population, rising healthcare expenditures, and expanding medical infrastructure. The adoption of minimally invasive spinal procedures is also gaining traction in these regions.

Integration of Robotics and AI in Spinal Surgeries

The incorporation of robotic-assisted surgery and AI-driven imaging systems in spinal procedures enhances precision and safety, reducing the risk of complications. These advancements are expected to open new avenues for market expansion.

Expansion of Outpatient and Ambulatory Surgery Centers

The rising number of ambulatory surgery centers (ASCs) is fueling demand for minimally invasive procedures, including vertebroplasty and kyphoplasty. The preference for outpatient settings over traditional hospital stays is anticipated to boost procedural volumes.

Market by Device Type Insights

The Balloon Kyphoplasty Devices segment accounted for the largest market share in 2023. Balloon kyphoplasty offers better vertebral height restoration and lower risks of cement leakage compared to traditional vertebroplasty, making it the preferred treatment option.

The Vertebroplasty Devices segment is also growing steadily, driven by its cost-effectiveness and ease of use in treating vertebral fractures.

Market by End-Use Insights

Hospitals Segment Leading the Market

The Hospitals segment emerged as the dominant end-user in 2023, owing to the availability of advanced imaging systems, specialized orthopedic and neurosurgical teams, and comprehensive post-operative care.

Ambulatory Surgery Centers (ASCs) Gaining Traction

ASCs are witnessing significant growth due to their cost-effectiveness, shorter hospital stays, and improved patient convenience, making them a preferred choice for minimally invasive spinal procedures.

Market by Regional Insights

North America Leading the Market

North America held the largest market share in 2023, primarily due to the high prevalence of osteoporosis, advanced healthcare infrastructure, and strong adoption of minimally invasive procedures. The U.S. remains the dominant market due to favorable reimbursement policies and the presence of leading medical device manufacturers.

Asia-Pacific to Register the Fastest Growth

Asia-Pacific is expected to witness the highest growth rate during the forecast period, driven by an aging population, increasing awareness of spinal health, and growing investments in healthcare facilities in countries such as China, Japan, and India.

Competitive Scenario

Key players in the Global Vertebroplasty and Kyphoplasty Device Market include:

Medtronic plc

Stryker Corporation

Johnson & Johnson (DePuy Synthes)

Globus Medical, Inc.

Zimmer Biomet Holdings, Inc.

Osseon LLC

Alphatec Holdings, Inc.

Seaspine Holdings Corporation

Izi Medical Products

Key Market Developments

2023: Medtronic launched an advanced balloon kyphoplasty system with improved bone cement delivery technology.

2023: Stryker expanded its portfolio of minimally invasive spinal fracture treatments with the introduction of a next-generation vertebral augmentation device.

2024: Johnson & Johnson (DePuy Synthes) announced a strategic partnership with a leading AI-driven imaging company to enhance precision in spinal fracture treatments.

2025: Zimmer Biomet introduced a robotic-assisted vertebroplasty system aimed at improving surgical accuracy and outcomes.

Scope of Work – Global Vertebroplasty and Kyphoplasty Device Market

Report Metric

Details

Market Size (2023)

USD 1.2 billion

Projected Market Size (2031)

USD 2.4 billion

CAGR (2023-2031)

9.1%

Market Segments

By Device Type (Balloon Kyphoplasty Devices, Vertebroplasty Devices), By End-Use (Hospitals, Ambulatory Surgery Centers)

Growth Drivers

Increasing prevalence of osteoporosis, rising adoption of minimally invasive procedures, technological advancements in spinal treatment devices

Opportunities

Expansion in emerging markets, integration of robotics and AI, growing adoption in outpatient settings

Report Metric Details

Market Size (2023) USD 1.2 billion

Projected Market Size (2031) USD 2.4 billion

CAGR (2023-2031) 9.1%

Market Segments By Device Type (Balloon Kyphoplasty Devices, Vertebroplasty Devices), By End-Use (Hospitals, Ambulatory Surgery Centers)

Growth Drivers Increasing prevalence of osteoporosis, rising adoption of minimally invasive procedures, technological advancements in spinal treatment devices

Opportunities Expansion in emerging markets, integration of robotics and AI, growing adoption in outpatient settings

Frequently Asked Questions (FAQs)

1. What is the current market size of the Global Vertebroplasty and Kyphoplasty Device Market?

The market was valued at USD 1.2 billion in 2023 and is projected to reach USD 2.4 billion by 2031.

2. What is the major growth driver of the Global Vertebroplasty and Kyphoplasty Device Market?

The increasing prevalence of osteoporosis and the growing adoption of minimally invasive spinal procedures are key growth drivers.

3. Which is the largest region during the forecast period in the Global Vertebroplasty and Kyphoplasty Device Market?

North America is expected to dominate the market due to a well-established healthcare system and high prevalence of spinal fractures.

4. Which segment accounted for the largest market share in the Global Vertebroplasty and Kyphoplasty Device Market?

The Balloon Kyphoplasty Devices segment led the market in 2023, driven by its effectiveness in vertebral height restoration and reduced risk of cement leakage.

5. Who are the key market players in the Global Vertebroplasty and Kyphoplasty Device Market?

Major players include Medtronic plc, Stryker Corporation, Johnson & Johnson (DePuy Synthes), Globus Medical, Zimmer Biomet, Osseon LLC, and Alphatec Holdings.

This report provides comprehensive insights into the Global Vertebroplasty and Kyphoplasty Device Market, covering market size, drivers, restraints, opportunities, competitive landscape, and key market developments to help stakeholders make informed decisions. 

Download Sample Report

Speak with an analyst to get exclusive insights tailored to your needs

Related Reports

Related report image
Global Venous thromboembolism(VTE)Therapeutics Market By Type (Deep Vein Thrombosis(DVT),Pulmonary E...

The Global Venous Thromboembolism (VTE) Therapeutics Market was valued at USD 1.8 billion in 2023 an...

Read More
Related report image
Global Vein Illumination Device Market By Type (Transillumination, Infrared Technology, Ultrasound)...

The Global Vein Illumination Device Market was valued at USD 200 million in 2023 and is projected to...

Read More
Related report image
Global Vasculitis Treatment Market By Type (Large Vasculitis Treatment, Medium Vasculitis Treatment,...

The Global Vasculitis Treatment Market was valued at USD 500 million in 2023 and is projected to rea...

Read More
Related report image
Global Vascular Guidewires Market By Type (Nitinol, Stainless Steel, Hybrid), By Application (Hospi...

The Global Vascular Guidewires Market was valued at USD 1.3 billion in 2023 and is projected to reac...

Read More
Related report image
Global Vagus nerve stimulation Market By Type (Implantable VNS Devices, External VNS Devices), By Ap...

The Global Vagus Nerve Stimulation (VNS) Market was valued at USD 625 million in 2023 and is projec...

Read More
Related report image
Global In-line UV-Vis Spectroscopy Market By Type (Color Measurement, Chemical Concentration, Turbid...

The In-line UV-Vis Spectroscopy Market is expected to grow at a CAGR of 10.2% between 2023 and 2030,...

Read More
Related report image
Global Venturi Masks Market By Type (24% Oxygen Masks, 28% Oxygen Masks, 31% Oxygen Masks, 35% Oxyge...

Between the years 2023 and 2030, it is anticipated that the Global Venturi Masks Market will experie...

Read More
Related report image
Global Knee Massager Market By Type (Knee Massager,Knuckle Massager,Elbow Massager), By Application...

The growing awareness of joint health and the rising incidence of knee-related conditions like arthr...

Read More
Related report image
Global Mechanical Thrombectomy Devices Market By Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary...

The Global Mechanical Thrombectomy Devices Market was valued at USD 1.3 billion in 2023 and is proje...

Read More
Related report image
Global Vaginal Slings Market By Type (Biologic, Synthetic Slings), By Application (Clinics, Hospital...

The Global Vaginal Slings Market was valued at USD 1.1 billion in 2023 and is projected to reach USD...

Read More